CLEVELAND — Voters across Cleveland cast their ballots Tuesday night in a municipal primary that will help determine key leadership roles that could shape the city's immediate future and send ripple ...

NEW HAVEN, Conn. (WTNH) — News 8 is your local election headquarters, and voting took place Tuesday in 21 communities across Connecticut. Two key races News 8 is watching are the Democratic mayoral ...

Positive results from the global COAST 1 phase 3 study (clinical study identifier: NCT06130566) showed that amlitelimab, a fully human non-T cell depleting monoclonal antibody that targets OX40-ligand ...

Sanofi’s amlitelimab met all primary and key secondary endpoints in the COAST 1 phase 3 study in adults and adolescents with atopic dermatitis Amlitelimab, dosed every four weeks or every 12 weeks, ...

Amlitelimab, dosed every four weeks or every 12 weeks, demonstrated statistically significant and clinically meaningful efficacy in skin clearance and disease severity compared to placebo at Week 24, ...

Merck, known as MSD outside of the United States and Canada, announced positive topline results from the phase 3 CORALreef Lipids trial evaluating the safety and efficacy of enlicitide decanoate, an ...

Photoshop CC 2014 tutorial showing how to transform a photo of a person into a powerful, “high key” portrait and add text to it to create a dynamic, elegant poster.

Enlicitide is the first oral PCSK9 inhibitor to demonstrate statistically significant and clinically meaningful reductions in LDL-C compared to placebo in Phase 3 trials RAHWAY, N.J.--(BUSINESS WIRE)- ...